Ankit Mangla, Md

This study tests a new medicine, BMS-986504, in people with a rare nerve sheath cancer (MPNST) that cannot be removed by surgery. Only patients whose tumors have a specific gene deletion (MTAP) can join. The goal is to see if the drug can shrink tumors or slow the cancer, and to …